Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Evidone SA

History from 1 Feb 2024

UID
CHE-373.495.685
Legal form
AG
Canton
VD
Founded
1 Feb 2024
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 114k
28k57k85k114k20 Apr 2026 · CHF 113k9 Jul 2026 · CHF 114k
  • all shares
  • shares

Record

  1. Company formed

    Founded 1 Feb 2024

    SHAB HR01-1005961291 ↗
  2. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    100’000 → 113’333.33
    Shares
    — → 113’333’333
    New shares, % of post-step shares
    — (share counts not published)

    Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 113'333.33, divisé en 113'333'333 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. L'assemblée générale a introduit une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 30.03.2026; pour les détails, voir les statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006629918 ↗
  3. Capital band adopted

    SHAB HR02-1006629918 ↗
  4. Capital increase

    Capital increased · undecided

    Paid in cash

    Nominal capital
    113’333.33 → 113’833.33
    Shares
    113’333’333 → 11’383’333
    New shares, % of post-step shares
    — (no new shares)

    Augmentation ordinaire du capital-actions dans la limite de la marge de fluctuation du capital. Nouveau capital-actions entièrement libéré: CHF 113'833.33, divisé en 11'383'333 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. Le conseil d'administration a modifié une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 26.06.2026; pour les détails, voir les statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.35 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006702702 ↗
  5. Capital band changed

    SHAB HR02-1006702702 ↗

Published by 8 Oct 2026